Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Publication year range
1.
Radiologia (Engl Ed) ; 66 Suppl 1: S24-S31, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38642957

ABSTRACT

INTRODUCTION: There are no defined criteria for deciding to remove a non-functioning indwelling pleural catheter (IPC) when lung re-expansion on chest X-ray is incomplete. Chest computed tomography (chest CT) is usually used. The objective of this work is to validate the usefulness of chest ultrasound performed by a pulmonologist and by a radiologist compared to chest CT. PATIENTS AND METHODS: Prospective, descriptive, multidisciplinary and multicenter study including patients with malignant pleural effusion and non-functioning IPC without lung reexpansion. Decisions made on the basis of chest ultrasound performed by a pulmonologist, and performed by a radiologist, were compared with chest CT as the gold standard. RESULTS: 18 patients were analyzed, all of them underwent ultrasound by a pulmonologist and chest CT and in 11 of them also ultrasound by a radiologist. The ultrasound performed by the pulmonologist presents a sensitivity of 60%, specificity of 100%, PPV 100% and NPV 66% in the decision of the correct removal of the IPC. The concordance of both ultrasounds (pulmonologist and radiologist) was 100%, with a kappa index of 1. The 4 discordant cases were those in which the IPC was not located on the ultrasound. CONCLUSIONS: Thoracic ultrasound performed by an expert pulmonologist is a valid and simple tool to determine spontaneous pleurodesis and remove a non-functioning IPC, which would make it possible to avoid chest CT in those cases in which lung reexpansion is observed with ultrasonography.


Subject(s)
Pleural Effusion, Malignant , Humans , Pleural Effusion, Malignant/diagnostic imaging , Pleural Effusion, Malignant/therapy , Pleural Effusion, Malignant/pathology , Prospective Studies , Catheterization , Catheters, Indwelling , Ultrasonography
2.
Cir. Esp. (Ed. impr.) ; 100(11): 673-683, nov. 2022. tab, ilus
Article in Spanish | IBECS | ID: ibc-212469

ABSTRACT

Este artículo resume la guía clínica de diagnóstico y tratamiento del derrame pleural maligno (DPM) auspiciada por la Sociedad Española de Cirugía Torácica (SECT). Se elaboraron 10 controversias clínicas bajo la metodología de preguntas PICO (Patient, Intervention, Comparison, Outcome) y la calidad de la evidencia y graduación de la fuerza de las recomendaciones se basó en el sistema Grading of Recommendations, Assessment, Development and Evaluations (GRADE). El análisis inmunocitoquímico y molecular del líquido pleural puede evitar procedimientos invasivos ulteriores con finalidad diagnóstica. Actualmente, el control definitivo del DPM se puede realizar indistintamente a través de una pleurodesis (talco poudrage o slurry) o de la inserción de un catéter pleural tunelizado (CPT). Es probable que la combinación de ambas técnicas (p.ej. toracoscopia con talco poudrage e inserción de un CPT, o instilación de talco slurry a través de un CPT) ocupe un lugar predominante en el manejo terapéutico futuro. (AU)


This article summarizes the clinical guidelines for the diagnosis and treatment of malignant pleural effusion (MPE) sponsored by the Spanish Society of Thoracic Surgery (SECT). Ten clinical controversies were elaborated under the methodology of PICO (Patient, Intervention, Comparison, Outcome) questions and the quality of the evidence and grading of the strength of the recommendations was based on the GRADE system. Immunocytochemical and molecular analyses of pleural fluid may avoid further invasive diagnostic procedures. Currently, the definitive control of MPE can be achieved either by pleurodesis (talc poudrage or slurry) or the insertion of a indwelling pleural catheter (IPC). It is likely that the combination of both techniques (i.e., thoracoscopy with talc poudrage and insertion of a IPC, or instillation of talc slurry through a IPC) will have a predominant role in the future therapeutic management. (AU)


Subject(s)
Humans , Thoracic Surgery , Pleural Effusion, Malignant , Pleurodesis , Spain , Societies, Scientific , Catheters
3.
Cir Esp (Engl Ed) ; 100(11): 673-683, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35667609

ABSTRACT

This article summarizes the clinical guidelines for the diagnosis and treatment of malignant pleural effusion (MPE) sponsored by the Spanish Society of Thoracic Surgery (SECT). Ten clinical controversies were elaborated under the methodology of PICO (Patient, Intervention, Comparison, Outcome) questions and the quality of the evidence and grading of the strength of the recommendations was based on the GRADE system. Immunocytochemical and molecular analyses of pleural fluid may avoid further invasive diagnostic procedures. Currently, the definitive control of MPE can be achieved either by pleurodesis (talc poudrage or slurry) or the insertion of a indwelling pleural catheter (IPC). It is likely that the combination of both techniques (i.e., thoracoscopy with talc poudrage and insertion of a IPC, or instillation of talc slurry through a IPC) will have a predominant role in the future therapeutic management.


Subject(s)
Pleural Effusion, Malignant , Thoracic Surgery , Humans , Pleural Effusion, Malignant/surgery , Pleural Effusion, Malignant/drug therapy , Talc/therapeutic use , Pleurodesis/methods , Catheters, Indwelling
4.
s.l; Cir. esp. (Internet, Engl. ed.); jul. 2, 2022.
Non-conventional in Spanish | BIGG - GRADE guidelines | ID: biblio-1379801

ABSTRACT

This article summarizes the clinical guidelines for the diagnosis and treatment of malignant pleural effusion (MPE) sponsored by the Spanish Society of Thoracic Surgery (SECT). Ten clinical controversies were elaborated under the methodology of PICO (Patient, Intervention, Comparison, Outcome) questions and the quality of the evidence and grading of the strength of the recommendations was based on the GRADE system. Immunocytochemical and molecular analyses of pleural fluid may avoid further invasive diagnostic procedures. Currently, the definitive control of MPE can be achieved either by pleurodesis (talc poudrage or slurry) or the insertion of a tunneled pleural catheter (TPC). It is likely that the combination of both techniques (i.e., thoracoscopy with talc poudrage and insertion of a TPC, or instillation of talc slurry through a TPC) will have a predominant role in the future therapeutic management.


Este artículo resume la guía clínica de diagnóstico y tratamiento del derrame pleural maligno (DPM) auspiciada por la Sociedad Española de Cirugía Torácica (SECT). Se elaboraron 10 controversias clínicas bajo la metodología de preguntas PICO (Patient, Intervention, Comparison, Outcome) y la calidad de la evidencia y graduación de la fuerza de las recomendaciones se basó en el sistema Grading of Recommendations, Assessment, Development and Evaluations (GRADE). El análisis inmunocitoquímico y molecular del líquido pleural puede evitar procedimientos invasivos ulteriores con finalidad diagnóstica. Actualmente, el control definitivo del DPM se puede realizar indistintamente a través de una pleurodesis (talco poudrage o slurry) o de la inserción de un catéter pleural tunelizado (CPT). Es probable que la combinación de ambas técnicas (p.ej. toracoscopia con talco poudrage e inserción de un CPT, o instilación de talco slurry a través de un CPT) ocupe un lugar predominante en el manejo terapéutico futuro.


Subject(s)
Humans , Thoracoscopy , Pleural Effusion, Malignant/diagnostic imaging , Pleurodesis , Thoracic Surgery/methods , Thoracic Surgery, Video-Assisted/methods
5.
Rev. colomb. cancerol ; 26(1): 14-21, ene.-mar. 2022. tab
Article in Spanish | LILACS | ID: biblio-1407968

ABSTRACT

Resumen Revisión narrativa sobre cómo el cáncer altera la fisiología de la pleura, cómo se estudia el derrame pleural maligno y cómo se puede brindar paliación al paciente con derrame pleural mediante el catéter pleural permanente tunelizado, cuyo uso demuestra mayores beneficios en diferentes ámbitos clínicos, siendo utilizado principalmente para el tratamiento del derrame pleural tumoral recurrente, pero también en algunos casos de derrame pleural benigno repetitivo, convirtiéndolo en un recurso terapéutico útil en el cáncer avanzado.


Abstract This narrative review examines how cancer causes changes in pleural physiology, how to study malignant pleural effusion, and how to bring palliative care to patients with pleural effusion by means of indwelling tunneled pleural catheter. This catheter shows greater benefits in clinical practice, being used mainly for the treatment of recurrent malignant pleural effusion, but also in some cases of recurrent benign pleural effusion, making it a useful therapeutic tool in advanced cancer.


Subject(s)
Humans , Palliative Care , Pleural Effusion , Pleural Effusion, Malignant , Therapeutics , Catheters
6.
Rev. colomb. cir ; 35(3): 404-413, 2020. fig
Article in Spanish | LILACS | ID: biblio-1123170

ABSTRACT

Introducción. La transmisión del SARS-CoV-2 principalmente se da por gotas y contacto cercano con las per-sonas infectadas, pero los aerosoles parecen ser también una fuente de infección. El neumotórax espontáneo o secundario puede presentarse en pacientes con COVID-19, ayudado por patologías de base como la enfermedad pulmonar obstructiva crónica. Es necesario garantizar procedimientos seguros para los pacientes y buscar todas las medidas posibles para la protección del personal de la salud, por eso el drenaje de neumotórax con catéter pleural en lugar de sonda de toracostomía puede ser una de ellas.El objetivo de este estudio es presentar a los cirujanos una alternativa a la toracostomía tradicional, mediante la utilización de catéteres de menor diámetro, para la resolución de la ocupación pleural.Aspectos Técnicos. Se presenta el protocolo para inserción segura de un catéter pleural para el drenaje de neumotórax, mediante un sistema completamente cerrado, y se dan recomendaciones sobre el uso de filtros virales y solución viricida en el sistema de drenaje pleural conectado al catéter. Conclusión. El estado de pandemia por COVID-19 y el riesgo que representa para los profesionales de la salud la exposición a fuentes de transmisión durante procedimientos generadores de aerosoles, hace que se deban extremar las medidas para evitar el contagio.


Introduction. The transmission of SARS-CoV-2 mainly occurs by drops and close contact with infected people, but aerosols also seem to be a source of infection. Spontaneous or secondary pneumothorax can occur in patients with COVID-19, helped by underlying pathologies such as chronic obstructive pulmonary disease. It is necessary to guarantee safe procedures for patients and to seek all possible measures for the protection of health personnel, so drainage of pneumothorax with a pleural catheter instead of a thoracostomy tube may be one of those. The objective of this study is to present surgeons with an alternative to traditional thoracostomy, using smaller diameter catheters, to resolve pleural occupancy.Technical aspects. The protocol for the safe insertion of a pleural catheter for pneumothorax drainage is presented, using a completely closed system, and recommendations are given on the use of viral filters and viricidal solution in the pleural drainage system connected to the catheter.Conclusions. The state of the COVID-19 pandemic and the risk that exposure to sources of transmission sources during aerosol-generating procedures represents for health professionals means that extreme measures must be taken to avoid contagion.


Subject(s)
Humans , Betacoronavirus , Pneumothorax , Thoracostomy , Coronavirus Infections
7.
Arch Bronconeumol ; 53(11): 629-636, 2017 Nov.
Article in English, Spanish | MEDLINE | ID: mdl-28641878

ABSTRACT

Various clinical trials have been published on the optimal clinical management of patients with pleural exudates, particularly those caused by malignant tumors, while little information is available on the diagnosis and treatment of pleural transudates. The etiology of pleural transudates is wide and heterogeneous, and they can be caused by rare diseases, sometimes constituting a diagnostic challenge. Analysis of the pleural fluid can be a useful procedure for establishing diagnosis. Treatment should target not only the underlying disease, but also management of the pleural effusion itself. In cases refractory to medical treatment, invasive procedures will be necessary, for example therapeutic thoracentesis, pleurodesis with talc, or insertion of an indwelling pleural catheter. Little evidence is currently available and no firm recommendations have been made to establish when to perform an invasive procedure, or to determine the safest, most efficient approach in each case. This article aims to describe the spectrum of diseases that cause pleural transudate, to review the diagnostic contribution of pleural fluid analysis, and to highlight the lack of evidence on the efficacy of invasive procedures in the management and control of pleural effusion in these patients.


Subject(s)
Exudates and Transudates , Pleural Effusion , Diuretics/therapeutic use , Drainage , Exudates and Transudates/chemistry , Heart Failure/complications , Humans , Hydropneumothorax/complications , Hypertension, Portal/complications , Liver Cirrhosis/complications , Peritoneal Dialysis/adverse effects , Pleural Effusion/diagnosis , Pleural Effusion/etiology , Pleural Effusion/physiopathology , Pleural Effusion/therapy , Pleural Effusion, Malignant/etiology , Pleurodesis , Thoracentesis , Tomography, X-Ray Computed
8.
Rev Clin Esp (Barc) ; 217(6): 336-341, 2017.
Article in English, Spanish | MEDLINE | ID: mdl-28479076

ABSTRACT

In this narrative review we describe the main aetiologies, clinical characteristics and treatment for patients with benign pleural effusion that characteristically persists over time: chylothorax and cholesterol effusions, nonexpansible lung, rheumatoid pleural effusion, tuberculous empyema, benign asbestos pleural effusion and yellow nail syndrome.

SELECTION OF CITATIONS
SEARCH DETAIL
...